70.70
price up icon3.02%   2.07
after-market Dopo l'orario di chiusura: 70.92 0.22 +0.31%
loading

Monopar Therapeutics Inc Azioni (MNPR) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - 0.0735
Operating Expenses
0.39%
3.2343
3.2218 11.07 1.5749 1.7888
Operating Income/Loss
0.39%
-3.2343
-3.2218 -11.07 -1.5749 -1.7888
Income/Loss From Continuing Operations Before Tax
6.53%
-2.4535
-2.625 -10.92 -1.3043 -1.7153
Income/Loss From Continuing Operations After Tax
6.53%
-2.4535
-2.625 -10.93 -1.3043 -1.7153
Net Income/Loss
6.53%
-2.4535
-2.625 -10.93 -1.3043 -1.7153
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.15%
6.9981
6.9874 0.3709 3.5204 17.51
Basic Earnings Per Share
7.89%
-0.35
-0.38 -2.75 -0.37 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.86
price up icon 0.67%
$100.71
price down icon 1.93%
$33.06
price up icon 2.10%
$92.17
price down icon 0.36%
biotechnology ONC
$313.36
price down icon 0.85%
$175.76
price up icon 0.53%
Capitalizzazione:     |  Volume (24 ore):